Company Overview
HealthStream, Inc. operates within the Healthcare sector, specifically focusing on the Health Information Services industry, where it delivers specialized Software-as-a-Service (SaaS) applications to healthcare organizations across the United States. The company's core offerings include the hStream technology platform and CredentialStream, which provides essential tools for managing the provider lifecycle from recruitment through credentialing. As a mid-cap enterprise, the company holds a market capitalization of $626.00M, supported by an annual revenue stream of $304.06M and a workforce of 1,139 employees. These valuation and revenue figures indicate that HealthStream maintains a significant operational footprint within the niche market for healthcare information services, balancing established market presence with the scale required to sustain SaaS infrastructure costs.
Financial Health
The company reported total revenue of $304.06M over the trailing twelve months, generating net income of $18.34M and EBITDA of $38.31M, a disparity that highlights a substantial cost structure where operational expenses consume a significant portion of gross revenue before reaching the bottom line. Free cash flow stands at $46.60M, which exceeds the reported net income, suggesting that the company generates sufficient cash to cover capital expenditures and operational needs, thereby providing a degree of financial flexibility for reinvestment or debt servicing. The gross margin is recorded at 64.7%, reflecting the typical high-margin nature of SaaS business models, while the operating margin sits at 3.6% and the profit margin at 6.0%, indicating that high fixed costs or specific operational inefficiencies are compressing the spread between revenue and net earnings. On the balance sheet, the company holds $57.00M in cash against $17.58M in debt, resulting in a debt-to-equity ratio of 4.96, which presents a leveraged profile where equity is significantly smaller than the total debt load, yet the high cash balance offers a buffer against interest obligations. The current ratio is 0.96, which indicates that current assets are slightly below current liabilities, suggesting a tight short-term liquidity position where the company must manage working capital carefully to meet obligations. Return on equity is 5.1% and return on assets is 2.5%, metrics that reveal management is generating modest returns on the capital invested, a characteristic often seen in capital-intensive or highly regulated sectors where asset turnover may be slow.
Valuation Assessment
The trailing twelve-month P/E ratio is 34.59, while the forward P/E is 24.53, implying that the market expects earnings growth to accelerate significantly in the coming year to justify the lower forward multiple compared to the historical average. The price-to-book ratio is 1.76, indicating that the market values the company at a premium of 76% above its net book value, which often reflects intangible assets, brand value, or growth potential not captured on the balance sheet. Alternative valuation metrics such as the price-to-sales ratio of 2.06 and the EV/EBITDA of 15.14 provide context for the company's valuation relative to its revenue generation and operating earnings, suggesting the market is willing to pay a moderate multiple for its sales volume. The stock has traded between a 52-week high of $34.13 and a 52-week low of $19.50, placing the current market price at a level that reflects recent volatility but remains within the historical trading range observed over the last year. With a beta of 0.46, the stock exhibits low price volatility relative to the broader market, moving less than half as much as the market index, which may appeal to investors seeking stability within the healthcare sector.
Growth & Income
Revenue growth for the trailing twelve months stands at 7.4%, whereas earnings growth is -46.5%, indicating that earnings are currently growing at a significantly slower rate than revenue, likely due to margin compression or one-time expenses impacting the bottom line. The company offers a dividend yield of 0.6% with a payout ratio of 20.3%, a low payout that suggests the company retains the majority of its earnings for internal growth rather than distributing them to shareholders, making the dividend relatively sustainable given the earnings decline. The divergence between positive revenue growth and negative earnings growth highlights the challenge the company faces in converting top-line expansion into bottom-line profitability during this specific period. Overall, HealthStream presents a profile of steady top-line expansion in a specialized SaaS sector, tempered by significant earnings volatility and a conservative dividend policy that prioritizes capital retention over income distribution.